The Korean branch of Gilead is facing the most significant transformation since its inception in Korea.

Various changes such as the establishment of a new business unit are expected along with changes in the composition of the workforce, such as the resignation of executive director Jeong Yeon-shin, a key member of Gilead Sciences Korea along with CEO Lee Seung-woo. First of all, CEO Lee Seung-woo will leave the company at the end of this month (March). Accordingly, Gilead is in the process of hiring a successor for CEO Lee. It is known that CEO Lee decided to retire with his resignation. CEO Lee is a symbol of a multinational company professional manager in the pharmaceutical industry.

H